These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8397057)

  • 1. Inhibition of IL-1 beta-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide alpha-MSH.
    Watanabe T; Hiltz ME; Catania A; Lipton JM
    Brain Res Bull; 1993; 32(3):311-4. PubMed ID: 8397057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiinflammatory influences of alpha-MSH molecules: central neurogenic and peripheral actions.
    Macaluso A; McCoy D; Ceriani G; Watanabe T; Biltz J; Catania A; Lipton JM
    J Neurosci; 1994 Apr; 14(4):2377-82. PubMed ID: 8158274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central neurogenic antiinflammatory action of alpha-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation.
    Ceriani G; Macaluso A; Catania A; Lipton JM
    Neuroendocrinology; 1994 Feb; 59(2):138-43. PubMed ID: 8127402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-MSH peptides inhibit acute inflammation induced in mice by rIL-1 beta, rIL-6, rTNF-alpha and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8.
    Hiltz ME; Catania A; Lipton JM
    Cytokine; 1992 Jul; 4(4):320-8. PubMed ID: 1325196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipyretic properties of centrally administered alpha-MSH fragments in the rabbit.
    Deeter LB; Martin LW; Lipton JM
    Peptides; 1988; 9(6):1285-8. PubMed ID: 2854626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide alpha-MSH.
    Hiltz ME; Lipton JM
    FASEB J; 1989 Sep; 3(11):2282-4. PubMed ID: 2550304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic alpha-MSH suppresses LPS fever via central melanocortin receptors independently of its suppression of corticosterone and IL-6 release.
    Huang QH; Hruby VJ; Tatro JB
    Am J Physiol; 1998 Aug; 275(2):R524-30. PubMed ID: 9688689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of peripheral interleukin-1 beta-induced hyperalgesia by the intracerebroventricular administration of diclofenac and alpha-melanocyte-stimulating hormone.
    Oka T; Oka K; Hosoi M; Hori T
    Brain Res; 1996 Oct; 736(1-2):237-42. PubMed ID: 8930329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated central administration of alpha-MSH does not alter the antipyretic effect of alpha-MSH in young and aged rabbits.
    Deeter LB; Martin LW; Lipton JM
    Peptides; 1989; 10(3):697-9. PubMed ID: 2550914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral analgesic activities of peptides related to alpha-melanocyte stimulating hormone and interleukin-1 beta 193-195.
    Poole S; Bristow AF; Lorenzetti BB; Das RE; Smith TW; Ferreira SH
    Br J Pharmacol; 1992 Jun; 106(2):489-92. PubMed ID: 1327383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxyl-terminal tripeptide of alpha-melanocyte-stimulating hormone antagonizes interleukin-1-induced anorexia.
    Uehara Y; Shimizu H; Sato N; Tanaka Y; Shimomura Y; Mori M
    Eur J Pharmacol; 1992 Sep; 220(2-3):119-22. PubMed ID: 1330615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory activity of alpha-MSH(11-13) analogs: influences of alteration in stereochemistry.
    Hiltz ME; Catania A; Lipton JM
    Peptides; 1991; 12(4):767-71. PubMed ID: 1788140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of systemic inflammation by central action of the neuropeptide alpha-melanocyte- stimulating hormone.
    Delgado Hernàndez R; Demitri MT; Carlin A; Meazza C; Villa P; Ghezzi P; Lipton JM; Catania A
    Neuroimmunomodulation; 1999; 6(3):187-92. PubMed ID: 10213917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alpha-MSH on sleep, behavior, and brain temperature: interactions with IL 1.
    Opp MR; Obál F; Krueger JM
    Am J Physiol; 1988 Dec; 255(6 Pt 2):R914-22. PubMed ID: 2849324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipyretic activity of a potent alpha-MSH analog.
    Holdeman M; Lipton JM
    Peptides; 1985; 6(2):273-5. PubMed ID: 3875837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidence for the involvement of endogenous alpha-MSH-like peptides in peripheral nerve regeneration.
    Plantinga LC; Verhaagen J; Edwards PM; Hali M; Brakkee JH; Gispen WH
    Peptides; 1995; 16(2):319-24. PubMed ID: 7784262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The administration of an alpha-MSH analogue reduces the serum release of IL-1 alpha and TNF alpha induced by the injection of a sublethal dose of lipopolysaccharides in the BALB/c mouse.
    Gonindard C; Goigoux C; Hollande E; D'Hinterland LD
    Pigment Cell Res; 1996 Jun; 9(3):148-53. PubMed ID: 8888314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide alpha-MSH antagonizes IL-6- and TNF-induced fever.
    Martin LW; Catania A; Hiltz ME; Lipton JM
    Peptides; 1991; 12(2):297-9. PubMed ID: 1648713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-MSH peptides inhibit acute inflammation and contact sensitivity.
    Hiltz ME; Lipton JM
    Peptides; 1990; 11(5):979-82. PubMed ID: 2284205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of anti-inflammatory alpha-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells.
    Lyson K; Ceriani G; Takashima A; Catania A; Lipton JM
    Neuroimmunomodulation; 1994; 1(2):121-6. PubMed ID: 7489322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.